Ausgabe 2/2017
Inhalt (25 Artikel)
Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis
Hope S. Rugo, Susan A. Melin, Jeff Voigt
Basal markers and prognosis in luminal breast cancer
Monica J. Engstrøm, Marit Valla, Anna M. Bofin
Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients
Catherine Bingham, Sandra V. Fernandez, Patricia Fittipaldi, Paul W. Dempsey, Karen J. Ruth, Massimo Cristofanilli, R. Katherine Alpaugh
Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing
Takehiro Yanagawa, Naofumi Kagara, Tomohiro Miyake, Tomonori Tanei, Yasuto Naoi, Masafumi Shimoda, Kenzo Shimazu, Seung Jin Kim, Shinzaburo Noguchi
A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women
Ling-Ming Tseng, Jen-Hwey Chiu, Chun-Yu Liu, Yi-Fang Tsai, Yun-Lin Wang, Chu-Wen Yang, Yi-Ming Shyr
Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer
Hyung Soon Park, Joohyuk Sohn, Seung Il Kim, Seho Park, Hyung Seok Park, Seul Ghi Gho, Hyun Cheol Chung, Soonmyung Paik, Gun Min Kim
Identification of frequent somatic mutations in inflammatory breast cancer
Naoko Matsuda, Bora Lim, Ying Wang, Savitri Krishnamurthy, Wendy Woodward, Ricardo H. Alvarez, Anthony Lucci, Vicente Valero, James M. Reuben, Funda Meric-Bernstam, Naoto T. Ueno
The impact of mastectomy type on the Female Sexual Function Index (FSFI), satisfaction with appearance, and the reconstructed breast’s role in intimacy
K. Rojas, M. Onstad, C. Raker, MA Clark, A. Stuckey, J. Gass
Lymphatico-venous anastomosis as treatment for breast cancer-related lymphedema: a prospective study on quality of life
Anouk J. M. Cornelissen, Melissa Kool, Tiara R. Lopez Penha, Xavier H. A. Keuter, Andrzej A. Piatkowski, E. Heuts, René R. W. J. van der Hulst, Shan Shan Qiu
Evaluation of changes to foot shape in females 5 years after mastectomy: a case–control study
Iwona Głowacka-Mrotek, Magdalena Sowa, Zygmunt Siedlecki, Tomasz Nowikiewicz, Wojciech Hagner, Wojciech Zegarski
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials
M. V. Dieci, A. Frassoldati, D. Generali, G. Bisagni, F. Piacentini, L. Cavanna, K. Cagossi, F. Puglisi, A. Michelotti, R. Berardi, G. Banna, A. Goubar, G. Ficarra, G. Griguolo, Pierfranco Conte, V. Guarneri
Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database
Megan C. Roberts, Dave P. Miller, Steven Shak, Valentina I. Petkov
Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer
Teresa M. Salgado, Emily J. Davis, Karen B. Farris, Souhiela Fawaz, Peter Batra, N. Lynn Henry
Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities
Garth H. Rauscher, Abigail Silva, Heather Pauls, Jonna Frasor, Marcelo G. Bonini, Kent Hoskins
Health-related quality of life in Black breast cancer survivors with and without triple-negative breast cancer (TNBC)
Susan T. Vadaparampil, Juliette Christie, Kristine A. Donovan, Jongphil Kim, Bianca Augusto, Monica L. Kasting, Cheryl L. Holt, Kimlin Ashing, Chanita Hughes Halbert, Tuya Pal
Breast cancer screening in patients with cancers other than breast
Robin B. Leopold, Alexander W. Thomas, Kyle F. Concannon, Alissa D. Correll, Catherine M. LaPenta, Stephen M. Maurer, Brian L. Sprague, Sally D. Herschorn, Claire F. Verschraegen
Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study
Kathleen Conway, Sharon N. Edmiston, Eloise Parrish, Christopher Bryant, Chiu-Kit Tse, Theresa Swift-Scanlan, Lauren E. McCullough, Pei Fen Kuan
Estrogen–progestin use and breast cancer characteristics in lean and overweight postmenopausal women
Olof J. Kjartansdottir, Lara G. Sigurdardottir, Elinborg J. Olafsdottir, Jon G. Jonasson, Giske Ursin, Laufey Tryggvadottir
Breast cancer subtype distribution is different in normal weight, overweight, and obese women
Victoria Gershuni, Yun R. Li, Austin D. Williams, Alycia So, Laura Steel, Elena Carrigan, Julia Tchou
Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients
Beth Crawford, Sophie B. Adams, Taylor Sittler, Jeroen van den Akker, Salina Chan, Ofri Leitner, Lauren Ryan, Elad Gil, Laura van ’t Veer
Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)
Gretchen G. Kimmick, Brittny Major, Jonathan Clapp, Jeff Sloan, Brandelyn Pitcher, Karla Ballman, Myra Barginear, Rachel A. Freedman, Andrew Artz, Heidi D. Klepin, Jacqueline M. Lafky, Judith Hopkins, Eric Winer, Clifford Hudis, Hyman Muss, Harvey Cohen, Aminah Jatoi, Arti Hurria, Jeanne Mandelblatt
Treatment of cutaneous metastases of breast cancer with electrochemotherapy: what is the magnitude of clinical benefit?
Luca G. Campana, Sara Galuppo, Sara Valpione
Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: a useful contributor to cutaneous disease control
M. Bourke, D. Soden, A. J. P. Clover
Oncoplastic surgery with omental flap reconstruction: a study of 200 cases
Alexandre Mendonça Munhoz, Rolf Gemperli, José Roberto Filassi